| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.22 | 6e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.18 | 8e-05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.23 | 0.0001 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |